Chris Pettigrew, Director of Research Investment
Chris completed a Bachelor of Laws, Bachelor of Science (with Honours in Biotechnology) and Doctorate at the University of Queensland. Prior to commencing his PhD studies with Prof Melissa Brown on the alternative splicing of breast cancer susceptibility genes, he worked with the Australian Law Reform Commission on their inquiry into the patenting of genetic material. After receiving his PhD Chris worked as a post-doctoral research fellow at University College Cork (Ireland) investigating the role of reactive oxygen species in survival signalling pathways in prostate cancer.
Chris moved to Boston (USA) in 2010 working first at the Boston Biomedical Research Institute and then the University of Massachusetts Medical School on skeletal muscle development and fascioscapulohumeral dystrophy (FSHD). Chris was appointed editor of “Trends in Molecular Medicine” in 2013, a reviews journal published by Cell Press, also contributing to “Trends in Parasitology” and aiding the launch of “Trends in Cancer”.
He has also worked extensively in science communication on blogs, podcasts and radio. In 2015 Chris returned to Australia and joined the NHMRC National Institute for Dementia Research as Senior Research Policy Officer, and was promoted to the role of Deputy Director in May 2016.